The pathophysiology of multiple sclerosis: The mechanisms underlying the production of symptoms and the natural history of the disease

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1390, 1999, Pages 1649-1673

  Smith, Kenneth J ^a   McDonald, W I ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

Axonal degeneration; Conduction block; Demyelination; Ectopic impulses; Inflammation; Pathophysiology

Indexed keywords

EID: 0033615464     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0510     Document Type: Article

References (263)

1. Andermann, F., Cosgrove, J. B. R., Lloyd-Smith, D. L., Gloor, P. & McNaughton, F. L. 1961 Facial myokymia in multiple sclerosis. Brain 84, 31-44.
2. Avis, S. P. & Pryse-Phillips, W. E. 1995 Sudden death in multiple sclerosis associated with sun exposure: a report of two cases. Can. J. Neurol. Sci. 22, 305-307.
3. Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V, Fu, Z. F., Tawadros, R. & Koprowski, H. 1995 Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl Acad. Sci. USA 92, 12041-12045.
4. Baker, M. & Bostock, H. 1992 Ectopic activity in demyelinated spinal root axons of the rat. J. Physiol. (Lond.) 451, 539-552.
5. Barnes, D., Munro, P. M., Youl, B. D., Prineas, J. W. & McDonald, W. I. 1991 The longstanding multiple sclerosis lesion. A quantitative MRI and electron microscopic study. Brain 114, 1271-1280.
6. Baron-Van Evercooren, A., Avellana-Adalid, V, Lachapelle, F. & Liblau, R. 1997 Schwann cell transplantation and myelin repair of the. CNS. Multiple sclerosis 3, 157-161.
7. Bellinger, F. P., Madamba, S. & Siggins, G. R. 1993 Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CAI hippocampus. Brain Res. 628, 227-234.
8. Berger, J. R. & Sheremata, W. A. 1983 Persistent neurological deficit precipitated by hot bath test in multiple sclerosis. J. Am. Med. Assoc. 249, 1751-1753.
9. Berger, J. R. & Sheremata, W. A. 1985 Reply to letter by F. A. Davis. J. Am. Med. Assoc. 253, 203.
10. Bever Jr, C. T. 1994 The current status of studies of aminopyridines in patients with multiple sclerosis. A. Neurol. 36(Suppl.), S118-S121.
11. Bever Jr, C. T. (and 12 others) 1994 The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial. Neurology 44,1054-1059.
12. Bianchi, M., Sacerdote, P., Ricciardi-Castagnoli, P., Mantegazza, P. & Panerai, A. E. 1992 Central effects of tumor necrosis factor alpha and interleukin-1 alpha on nociceptive thresholds and spontaneous locomotor activity. Neurosci. Lett. 148, 76-80.
13. Black, J. A. & Waxman, S. G. 1996 Sodium channel expression: a dynamic process in neurons and non-neuronal cells. Dev. Neurosci. 18, 139-152.
14. Black, J. A., Felts, R, Smith, K. J., Koesis, J. D. & Waxman, S. G. 1991 Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno-ultrastructural localization and electrophysiological observations. Brain Res. 544, 59-70.
15. Blakemore, W. F. & Smith, K. J. 1983 Node-like axonal specializations along demyelinated central nerve fibres: ultrastructural observations. Acta Neuropathol. 60, 291-296.
16. Blight, A. R., Toombs, J. P., Bauer, M. S. & Widmer, W. R. 1991 The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. J. Neurotrauma 8, 103-119.
17. Bo, L., Dawson, T. M., Wesselingh, S., Mork, S., Choi, S., Kong, P. A., Hanley, D. & Trapp, B. D. 1994 Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
18. Bolanos, J. P., Peuchen, S., Heales, S. J., Land, J. M. & Clark, J. B. 1994 Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 63, 910-916.
19. Bolanos, J. P., Almeida, A., Stewart, V., Peuchen, S., Land, J. M., Clark, J. B. & Heales, S. J. R. 1997 Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications For neurodegenerative diseases. J. Neurochem. 68, 2227-2240.
20. Bornstein, M. B. & Crain, S. M. 1965 Functional studies of cultured brain tissues as related to 'demyelinative disorders'. Science 148, 1242-1244.
21. Bostock, H. 1984 Internodal conduction along undissected nerve fibers in experimental neuropathy. In Peripheral neuropathy, 2nd edn (ed. P. J. Dyck, P. K. Thomas, E. H. Lambert & R. Bunge), pp. 900-910. Philadelphia, PA: W. B. Saunders.
22. Bostock, H. 1993 Impulse propagation in experimental neuropathy. In Peripheral neuropathy, 3rd edn (ed. P. J. Dyck, P. K. Thomas, J. W. Griffin, P. A. Low & J. F. Poduslo), pp. 109-120. Philadelphia, PA: W. B. Saunders.
23. Bostock, H. 1994 The pathophysiology of demyelination. In Multiple sclerosis: current status of research and treatment (ed. R. M. Herndon & F. J. Seil), pp. 89-112. New York: Demos Publications, Inc.
24. Bostock, H. & Grafe, P. 1985 Activity-dependent excitability changes in normal and demyelinated rat spinal root axons. J. Physiol. (Lond.) 365, 239-257.
25. Bostock, H. & Sears, T. A. 1976 Continuous conduction in demyelinated mammalian nerve fibers. Nature 263, 786-787.
26. Bostock, H. & Sears, T. A. 1978 The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J. Physiol. (Lond.) 280, 273-301.
27. Bostock, H., Sherratt, R. M. & Sears, T. A. 1978 Overcoming conduction failure in demyelinated nerve fibres by prolonging action potentials. Nature 274, 385-387.
28. Bostock, H., Sears, T. A. & Sherratt, R. M. 1981 The effects of 4-aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. J. Physiol. (Lond.) 313, 301-315.
29. Bowe, C. M., Koesis, J. D., Targ, E. F. & Waxman, S. G. 1987 Physiological effects of 4-aminopyridine on demyelinated mammalian motor and sensory fibers. Ann. Neurol. 22, 264-268.
30. Breland, A. E. & Currier, R. D. 1983 Scorpion venom and multiple sclerosis. Lancet 2, 1021.
31. Brickner, R. M. 1950 The significance of localised vasoconstrictions in multiple sclerosis. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 28, 236-244.
32. Brinkmeier, H., Kaspar, A., Wietholter, H. & Rudel, R. 1992 Interleukin-2 inhibits sodium currents in human muscle cells. Pflugers Arch. 420, 621-623.
33. Brinkmeier, H., Wollinsky, K. H., Seewald, M. J., Hulser, P. J., Mehrkens, H. H. & Rudel, R. 1993 Factors in the cerebrospinal fluid of multiple sclerosis patients interfering with voltage-dependent sodium channels. Neurosci. Lett. 156, 172-175.
34. Brinkmeier, H., Seewald, M. J., Wollinsky, K. H. & Rudel, R. 1996 On the nature of endogenous antiexcitatory factors in the cerebrospinal fluid of patients with demyelinating neurological disease. Muscle Nerve 19, 54-62.
35. Brismar, T. 1981 Specific permeability properties of demyelinated rat nerve fibres. Acta Physiol. Scand. 113, 167-176.
36. Brosnan, C. F., Litwak, M. S., Schroeder, C. E. Selmaj, K., Raine, C. S. & Arezzo, J. C. 1989 Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit. J. Neuroimmunol. 25, 227-239.
37. Brosnan, C. F., Cannella, R., Battistini, L. & Raine, C. S. 1995 Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology 45, S16-S21.
38. Brown, G. C., Bolanos J. P., Heales, S. J. & Clark, J. B. 1995 Nitric oxide produced by activated astrocytes rapidly and reversibly inhibits cellular respiration. Neurosci. Lett. 193, 201-204.
39. Bruck, W., Bitsch, A., Kolenda, H., Bruck, Y., Stiefel, M. & Lassmann, H. 1997 Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 42, 783-793.
40. Bunge, M. B. 1994 Transplantation of purified populations of Schwann cells into lesioned adult rat spinal cord. J. Neurol. 242, S36-S39.
41. Burchiel, K. J. 1980 Abnormal impulse generation in focally demyelinated trigeminal roots. J. Neurosurg. 53, 674-683.
42. CO2, pH, and disodium edetate. Ann. Neurol. 9, 378-383.
43. Burke, D. 1993 Microneurography, impulse conduction, and paresthesias. Muscle Nerve 16, 1025-1032.
44. Calvin, W. H., Loeser, J. D. & Howe, J. F. 1977 A neurophysiological theory for the pain mechanism of tic douloureux. Pain 3, 147-154.
45. Calvin, W. H., Devor, M. & Howe, J. F. 1982 Can neuralgias arise from minor demyelination? Spontaneous firing, mechano-sensitivity, and afterdischarge from conducting axons. Exp. Neurol. 75, 755-763.
46. Carels, G. & Cerf, J. A. 1969 Functional alterations produced in an isolated nerve center by serum from patients with multiple sclerosis. Int. Arch. Allergy Appl. Immunol. 36(Suppl.), 608-628.
47. Carrieri, P. B., Provitera, V, De Rosa, T., Tartaglia, G., Gorga, F. & Perrella, O. 1998 Profile of cerebrospinal fluid and serum cytokines in patients with relapsing remitting multiple sclerosis: a correlation with clinical activity. Immunopharmacol. Immunotoxicol. 20, 373-382.
48. Celesia, G. G. & Daly, R. F. 1977 Visual electroencephalographic computer analysis (VECA). A new electrophysiologic test for the diagnosis of optic nerve lesions. Neurology 27, 637-641.
49. Cerf, J. A. & Carels, G. 1966 Multiple sclerosis: serum factor producing reversible alterations in bioelectric responses. Science 152, 1066-1068.
50. Chalk, J. B., McCombe, P. A. & Pender, M. P. 1994 Conduction abnormalities are restricted to the central nervous system in experimental autoimmune encephalomyelitis induced by inoculation with proteolipid protein but not with myelin basic protein. Brain 117, 975-986.
51. Chalk, J. B., McCombe, P. A. & Pender, M. P. 1995 Restoration of conduction in the spinal roots correlates with clinical recovery from experimental autoimmune encephalomyelitis. Muscle Nerve 18, 1093-1100.
52. Chandler, S., Miller, K. M., Clements, J. M., Lury, J., Corkill, D., Anthony, D. C., Adams, S. E. & Gearing, A. J. 1997 Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J. Neuroimmunol. 72, 155-161.
53. Chao, C. C., Hu, S. & Peterson, P. K. 1995 Glia, cytokines, and neurotoxicity. Crit. Rev. Neurobiol. 9, 189-205.
54. Chin, S. Y. & Ritchie, J. M. 1981 Evidence for the presence of potassium channels in the paranodal region of acutely demyelinated mammalian single nerve fibres. J. Physiol. (Lond.) 313, 415-437.
55. Coles, A., Wing, M., Molyneux, P., Paolillo, A., Davies, C., Hale, G., Miller, D., Waldmann, H. & Compston, A. 1999 Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann. Neurol. (In the press.)
56. Crain, S. M., Bornstein, M. B. & Lennon, V. A. 1975 Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors. Exp. Neurol. 49, 330-335.
57. Cross, A. H., Manning, P. T., Keeling, R. M., Schmidt, R. E. & Misko, T. P. 1998 Peroxynitrite formation within the central nervous system in active multiple sclerosis. J. Neuroimmunol. 88, 45-56.
58. Cummins, T. R. & Waxman, S. G. 1997 Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly reprinting tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J. Neurosci. 17, 3503-3514.
59. D'Arcangelo, G., Crassi, F., Ragozzino, D., Santoni, A., Tancredi, V. & Euschi, F. 1991 Interferon inhibits synaptic potentiation in rat hippocampus. Brain Res. 564, 245-248.
60. Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H. & McDonald, W. I. 1994 Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117, 49-58.
61. Davie, C. A., Barker, G. J., Webb, S., Tofts, P. S., Thompson, A. J., Harding, A. E., McDonald, W. I. & Miller, D. H. 1995 Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118, 1583-1592.
62. Davis, F. A. 1985 Neurological deficits following the hot bath test in multiple sclerosis. J. Am. Med. Assoc. 253, 203.
63. Davis, F. A. & Jacobson, S. 1971 Altered thermal sensitivity in injured and demyelinated nerve. A possible model of temperature effects in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 34, 551-561.
64. Davis, F. A. & Schauf, C. L. 1981 Approaches to the development of pharmacological interventions in multiple sclerosis. Adv. Neurol. 31, 505-510.
65. Davis, F. A., Becker F. O., Michael, J. A. & Sorensen, E. 1970 Effect of intravenous sodium bicarbonate, disodium edetate (Na2EDTA), and hyperventilation on visual and oculomotor signs in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 33, 723-732.
66. Davis, F. A., Michael, J. A. & Tomaszewski, J. S. 1973 Fluctuation of motor function in multiple sclerosis related to circadian temperature variations. Dis. Nerv. Syst. 34, 33-36.
67. Davis, F. A., Schauf, C. L., Reed, B. J. & Kesler, R. L. 1975 Experimental studies of the effects of extrinsic factors on conduction in normal and demyelinated nerve. J. Neurol. Neurosurg. Psychiatr. 39, 442-448.
68. Davis, F. A., Bergen, D., Schauf, C., McDonald, I. & Deutsch, W. 1976 Movement phosphenes in optic neuritis: a new clinical sign. Neurology 26, 1100-1104.
69. De Groot, C. J., Ruuls, S. R., Theeuwes, J. W., Dijkstra, C. D. & Van der Valk, P. 1997 Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56, 10-20.
70. Dugandzija-Novakovic, S. & Shrager, P. 1995 Survival, development, and electrical activity of central nervous system myelinated axons exposed to tumor necrosis factor in vitro. J. Neurosci. Res. 40, 117-126.
71. + channels and node of Ranvier formation in remyelinating axons. J. Neurosci. 15, 492-503.
72. England, J. D., Gamboni, F., Levinson, S. R. & Finger, T. E. 1990 Changed distribution of sodium channels along demyelinated axons. Proc. Natl. Acad. Sci. USA 87, 6777-6780.
73. England, J. D., Levinson, S. R. & Shrager, P. 1996 Immunocytochemical investigations of sodium channels along nodal and internodal portions of demyelinated axons. Microsc. Res Tech. 34, 445-451.
74. Felts, P. A. & Smith, K. J. 1992 Conduction properties of central nerve fibers remyelinated by Schwann cells. Brain Res. 574, 178-192.
75. Felts, P. A. & Smith, K. J. 1994 The use of potassium channel blocking agents in the therapy of demyelinating diseases. Ann. Neurol. 36, 454.
76. Felts, P. A., Kapoor, R. & Smith, K. J. 1995 A mechanism for ectopie firing in central demyelinated axons. Brain 118, 1225-1231.
77. Felts, P. A., Baker, T. A. & Smith, K. J. 1997 Conduction in segmentally demyelinated mammalian central axons. J. Neurosci. 17, 7267-7277.
78. Felts, P. A., Decrinck, T. J., Ellisman, M. H., Levinson, S. R., Schwarz, T. L. & Smith, K. J. 1998 Sodium and potassium channel immunolocalisation in demyelinated and remyelinated central axons. Neuropathol. Appl. Neurobiol. 24, 154-155.
79. Frankenhaeuser, B. & Hodgkin, A. L. 1957 The action of calcium on the electrical propeties of squid axons. J. Physiol. (Lond.) 137, 218-244.
80. Franklin, R. J. & Blakemore, W. F. 1993 Requirements for Schwann cell migration within CNS environments: a viewpoint. Int. J. Dev. Neurosci. 11, 641-649.
81. Ghatak, N. R., Hirano, A., Lijtmaer, H. & Zimmerman, H. M. 1974 Asymptomatic demyelinated plaque in the spinal cord. Arch. Neurol. 30, 484-486.
82. Ghezzi, A., Montanini, R., Basso, P. F., Zaffaroni, M., Massimo, E. & Cazzullo, C. L. 1990 Epilepsy in multiple sclerosis. Eur. Neurol. 30, 218-223.
83. Gideon, P., Henriksen, O., Sperling, B., Christiansen, P., Olsen, T. S., Jorgensen, H. S. & Arlien-Soborg, P. 1992 Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: a proton magnetic resonance spectroscopy study. Stroke 23, 1566-1572.
84. Giovannoni, G., Heales, S. J., Silver, N. C., O'Riordan, J., Miller, R. F., Land, J. M., Clark, J. B. & Thompson, E. J. 1997 Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 145, 77-81.
85. Gledhill, R. F. & McDonald, W. I. 1977 Morphological characteristics of central demyelination and remyelination: a single-fiber study. Ann. Neurol. 1, 552-560.
86. Goodkin, D. E. 1998 Interferon beta therapy for multiple sclerosis. Lancet 352, 1486-1487.
87. Goodwin, J. L., Uemura, E. & Cunnick, J. E. 1995 Microglial release of nitric oxide by the synergistic action of beta-amyloid and IFN-gamma. Brain Res. 692, 207-214.
88. Goureau, O., Amiot, F., Dantry, F. & Courtois, Y. 1997 Controlof nitric oxide production by endogenous TNF-alpha in mouse retinal pigmented epithelial and Muller glial cells. Biochem. Biophys. Res. Commun. 240, 132-135.
89. Guthikonda, P., Baker, J. & Mattson, D. H. 1998 Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J. Neuroimmunol. 82, 133-139.
90. Guthrie, T. C. 1951 Visual and motor changes in patients with multiple sclerosis. Arch. Neurol. Psychiatr. 65, 437-451.
91. Hall, C. L., Compston, A. & Scolding, N. J. 1997 Beta-interferon and multiple sclerosis. Trends Neurosci. 20, 63-67.
92. Halliday, A. M., McDonald, W. I. & Mushin, J. 1972 Delayed visual evoked response in optic neuritis. Lancet 1, 982-985.
93. Halliday, A. M., McDonald, W. I. & Mushin, J. 1973 Visual evoked response in diagnosis of multiple sclerosis. Br. Med. J. 4, 661-664.
94. Harbison, J. W., Calabrese, V. P. & Edlich, R. F. 1989 A fatal case of sun exposure in a multiple sclerosis patient. J. Emerg. Med. 7, 465-467.
95. Hartung, H. P., Archelos, J. J., Zielasek, J., Gold, R., Koltzenburg, M., Reiners, K. H. & Toyka, K. V. 1995 Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology 45, S22-S32.
96. Hille, B. 1992 Ionic channels of excitable membranes, 2nd edn. Sunderland, MA: Sinauer Associates, Inc.
97. Hjorth, R. J. & Willison, R. G. 1973 The electromyogram in facial myokymia and hemifacial spasm. J. Neurol. Sci. 20, 117-126.
98. Holscher, C. 1997 Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci. 20, 298-303.
99. Honmou, O., Utzschneider, D. A., Rizzo, M. A., Bowe, C. M., Waxman, S. G. & Koesis, J. D. 1994 Delayed depolarization and slow sodium currents in cutaneous afferents. J. Neurophysiol. 71, 1627-1637.
100. Honmou, O., Felts, P. A., Waxman, S. G. & Koesis, J. D. 1996 Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J. Neurosci. 16, 3199-3208.
101. Hopper, C. L., Matthews, C. G. & Cleeland, C. S. 1972 Symptom instability and thermoregulation in multiple sclerosis. Neurology 22, 142-148.
102. Howe, J. F., Calvin, W. H. & Loeser, J. D. 1976 Impulses reflected from dorsal root ganglia and from focal nerve injuries. Brain Res. 116, 139-144.
103. Hu, S., Sheng, W. S., Peterson, P. K. & Chao, C. C. 1995 Differential regulation by cytokines of human astrocyte nitric oxide production. Glia 15, 491-494.
104. Hua, L. L., Liu, J. S. H., Brosnan, C. F. & Lee, S. C. 1998 Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta implications for multiple sclerosis. Ann. Neurol. 43, 384-387.
105. Huizar, P., Kuno, M. & Miyata, Y. 1975 Electrophysiological properties of spinal motoneurones of normal and dystrophic mice. J. Physiol. (Lond.) 248, 231-246.
106. Hume, A. L. & Waxman, S. G. 1988 Evoked potentials in suspected multiple sclerosis: diagnostic value and prediction of clinical course. J. Neurol. Sci. 83, 191-210.
107. Imaizumi,T., Lankford, K. L., Waxman, S. G., Greer, C. A. & Koesis, J. D. 1998 Transplanted olfactory ensheathing cells remyelinate and enhance axonal conduction in the demyelinated dorsal columns of the rat spinal cord. J. Neurosci. 18, 6176-6185.
108. Isaac, C., Li, D. K. B., Genton, M., Jardine, C., Grochowski, E., Palmer, M., Kastrukoff, L. F., Oger, J. & Paty, D.W. 1988 Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 38, 1511-1515.
109. Jacobs, L., Kaba, S. & Pullicino, P. 1994 The lesion causing continuous facial myokymia in multiple sclerosis. Arch. Neurol. 51, 1115-1119.
110. Jeffery, N. D. & Blakemore, W. F. 1997 Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120, 27-37.
111. Johnson, A. W., Land, J. M., Thompson, E. J., Bolanos, J. P., Clark, J. B. & Heales, S. J. 1995 Evidence for increased nitric-oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 58, 107.
112. Kaji, R. & Sumner, A. J. 1989a Effect of digitalis on central demyelinative conduction block in vivo. Ann. Neurol. 25, 159-165.
113. Kaji, R. & Sumner, A. J. 1989b Ouabain reverses conduction disturbances in single demyelinated nerve fibers. Neurology 39, 1364-1368.
114. Kaji, R., Suzumura, A. & Sumner, A. J. 1988 Physiological consequences of antiserum-mediated experimental demyelination in CNS. Brain 111, 675-694.
115. kaji, R., Happel, L. & Sumner, A. J. 1990 Effect of digitalis on clinical symptoms and conduction variables in patients with multiple sclerosis. Ann. Neurol. 28, 582-584.
116. Kanchandani, R. & Howe, J. G. 1982 Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. J. Neurol. Neurosurg. Psychiatr. 45, 308-312.
117. Kapoor, R., Brown, P., Thompson, P. D. & Miller, D. H. 1992 Propriospinal myoclonus in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 55, 1086-1088.
118. Kapoor, R., Smith, K. J., Felts, P. A. & Davies, M. 1993 Internodal potassium currents can generate ectopic impulses in mammalian myelinated axons. Brain Res. 611, 165-169.
119. Kapoor, R., Li, Y. G. & Smith, K. J. 1997 Slow sodium-dependent potential oscillations contribute to ectopic firing in mammalian demyelinated axons. Brain 120, 647-652.
120. Kapoor, R., Davies, M., Hall, S. M. & Smith, K. J. 1998 Nitric oxide causes axonal degeneration which is exacerbated by impulse activity J. Neurol. Neurosurg. Psychiatr. 65, 415.
121. Kara, P. & Friedlander, M. J. 1998 Dynamic modulation of cerebral cortex synaptic function by nitric oxide. Prog. Brain Res. 118, 183-198.
122. Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S. & McFarland, H. F. 1993 Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 34, 661-669.
123. Kermode, A. G., Thompson, A. J., Tofts, P., Macmanus, D. G., Kendall, B. E., Kingsley, D. P., Moseley, I. F., Rudge, P. & McDonald, W. I. 1990 Breakdown of the blood brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113, 1477-1489.
124. Kidd, D., Barkhof, F., McConnell, R., Algra, P. R., Allen, I. V. & Revesz, T. 1999 Cortical lesions in multiple sclerosis. Brain 122, 17-26.
125. Kilbinger, H. 1996 Modulation of acetylcholine release by nitric oxide. Prog. Brain Res. 109, 219-224.
126. Koles, A. J. & Rasminsky, M. 1972 A computer simulation of conduction in demyelinated nerve fibres. J. Physiol. (Lond.) 227, 351-364.
127. + current. Brain 119, 457-463.
128. Kurtzke, J. F. 1983 Rating neurologic impairment in multiple Sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444-1452.
129. Largo, C., Guevas, P., Somjen, G. G., Martin del Rio, R. & Herreras, O. 1996 The effect of depressing glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J. Neurosci. 16, 1219-1229.
130. Larsson, H. B. W., Frederiksen, J., Kjaer, L., Henriksen, O. & Olesen, J. 1988 In vivo determination of T1 and T2 in the brain of patients with severe but stable multiple sclerosis. Magnet. Res. Med. 7, 43-55.
131. Lee, S. G., Dickson, D. W. & Brosnan, C. F. 1995 Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav. Immunol. 9, 345-354.
132. Levine, R. A., Gardner, J. C., Fullerton, B. C., Stufflebeam, S. M., Furst, M. & Rosen, B. R. 1994 Multiple sclerosis lesions of the auditory pons are not silent. Brain 117, 1127-1141.
133. Lewis, R. A., Sumner, A. J., Brown, M. J. & Asbury, A. K. 1982 Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32, 958-964.
134. Lhermitte, J., Bollack, J. & Nicholas, M. 1924 Les douleurs à type de décharge électrique consécutives à la flexion céphalique dans la selérose en plaques. Rev. Neurol. 2, 56-62.
135. Li, Z., Chapleau, M. W., Bates, J. N., Bielefeldt, K., Lee, H.-C. & Abboud, F. M. 1998 Nitric oxide as an autocrine regulator of sodium currents in baroreceptor neurons. Neuron 20, 1039-1049.
136. Lin, J., Zhao, M. L., Brosnan, G. F. & Lee, S. G. 1996 Expression of type II nitric oxide synthase in primary human astrocytes and microglia: role of IL-lbeta and IL-I receptor antagonist. J. Immunol. 157, 3569-3576.
137. Losseff, N. A., Webb, S. L., O'Riordan, J. I., Page, R., Wang, L., Barker, G. J., Tofts, P. S., McDonald, W. I., Miller, D. H. & Thompson, A. J. 1996 Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119, 701-708.
138. Lumsden, C. E., Howard, L. & Aparicio, S. R. 1975a Antisynaptic antibody in allergic encephalomyelitis. I. Neurophysiological studies, in guinea pigs, on the exposed cerebral cortex and peripheral nerves, following immunological challenges with myelin and synaptosomes. Brain Res. 93, 267-282.
139. Lumsden, C. E., Howard, L., Aparicio, S. R. & Bradbury, M. 1975b Anti-synaptic antibody in allergic encephalomyelitis. II. The synapse-blocking effects in tissue culture of demyelinating sera from experimental allergic encephalomyelitis. Brain Res. 93, 283-299.
140. McDonald, I. 1998 Pathophysiology of multiple sclerosis. In McAlpine's multiple sclerosis, 3rd edn (ed. A. Compston, G. Ebers, H. Lassmann, W. I. McDonald, B. Matthews & H. Wekerle), pp. 359-378. London: Churchill Livingstone.
141. McDonald, W. I. 1975 Mechanisms of functional loss and recovery in spinal cord damage. Ciba Found. Symp. 34, 23-33.
142. McDonald, W. I. 1986 The pathophysiology of multiple sclerosis. In Multiple sclerosis (ed. W. I. McDonald & D. H. Silberberg), pp. 112-133. London: Butterworth.
143. McDonald, W. I. & Sears, T. A. 1969 Effect of demyelination on conduction in the central nervous system. Nature 221, 182-183.
144. McDonald, W. I. & Sears, T. A. 1970 The effects of experimental demyelination on conduction in the central nervous system. Brain 93, 583-598.
145. + channel. J. Biol. Chem. 274, 1381-1387.
146. Malhotra, A. S. & Goren, H. 1981 The hot bath test in the diagnosis of multiple sclerosis. J. Am. Med. Assoc. 246, 1113-1114.
147. Martiney, J. A., Litwak, M., Berman, J. W., Arezzo, J. C. & Brosnan, C. F. 1990 Pathophysiologic effect of interleukin-1b in the rabbit retina. Am. J. Pathol. 137, 1411-1423.
148. Matthews, B. 1998 Symptoms and signs of multiple sclerosis. In McAlpine's multiple sclerosis, 3rd edn (ed. A. Compston, G. Ebers, H. Lassmann, W. I. McDonald, B. Matthews & H. Wekerle), pp. 145-190. London: Churchill Livingstone.
149. Matthews, W. B. 1975 Paroxysmal symptoms in multiple sclerosis. J. Neurol, Neurosurg. Psychiatr. 38, 619-623.
150. Merrill, J. E. & Benveniste, E. N. 1996 Cytokinos in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 19, 331-338.
151. Miller, D. H., Rudge, P., Johnson, G., Kendall, B. E., Macmanus, D. G., Moseley, I. F., Barnes, D. & McDonald, W. T. 1988 Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111, 927-939.
152. Miller, D. H., Kesselring, J., McDonald, W. L., Paty, D. W. & Thompson, A. J. 1997 Magnetic resonance in multiple sclerosis. Cambridge University Press.
153. Miller, L. G. & Fahey, J. M. 1994 Interleukin-1 modulates GABAergic and glutamatergic function in brain. Am. NY Acad. Sci. 739, 292-298.
154. Milner, B. A., Regan, D. & Heron, J. R. 1974 Differential diagnosis of multiple sclerosis by visual evoked potential recording. Brain 97, 755-772.
155. Mimura, Y., Gotow, T., Nishi, T. & Osame, M. 1994 Mechanisms of hyperpolarization induced by two cytokines, hTNF alpha and hIL-1 alpha in neurons of the molluse, Onchidium. Brain Res. 653, 112-118.
156. Moll, C., Mourre, C., Lazdunski, M. & Ulrich, J. 1991 Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res. 556, 311-316.
157. Moreau, T., Coles, A., Wing, M., Isaacs, J., Hale, G., Waldmann, H. & Compston, A. 1996 Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119, 225-237.
158. Mottershead, J. P., Clements, M., Thornton, L. S., Scaravilli, F., Newcombe, J., Cuzuer, M. L., Ordidge, R., Miller, D. & McDonald, W. I. 1999 Correlation of myelin content, axonal density and NMR findings in the spinal cord post mortem in multiple sclerosis. J. Neurol. 245, 370.
159. Namerow, N. S. 1968 Gircadian temperature rhythm and vision in multiple sclerosis. Neurology 18, 417-422.
160. Namerow, N. S. 1972 The pathophysiology of multiple sclerosis. In Multiple sclerosis: immunology, virology and ultrastructure (ed. F. Wolfgram, G. W. Ellison, J. G. Stevens et al.), pp. 143-172. New York: Academic Press.
161. Navikas, V. & Link, H. 1996 Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45, 322-333.
162. Nordin, M., Nystrom, B., Wallin, U. & Hagbarth, K. E. 1984 Ectopic sensory discharges and paresthesiae in patients with disorders of peripheral nerves, dorsal roots and dorsal columns. Pain 20, 231-245.
163. + channels adjacent to remyelinating Schwann cells. J. Neurocytol. 25, 403-442.
164. Novakovic, S. D., Levinson, S. R., Schachner, M. & Shrager, P. 1998 Disruption and reorganization of sodium channels in experimental allergic neuritis. Muscle Nerve 21, 1019-1032.
165. Oleszak, E. L., Zaczynska, E., Bhattacharjee, M., Butunoi, C., Legido, A. & Katsetos, C. D. 1998 Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis. Clin. Diag. Lab. Immunol. 5, 438-445.
166. Ormerod, I. E. (and 14 others) 1987 The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 110, 1579-1616.
167. O'Riordan, J. I., Losseff, N. A., Phatouros, C., Thompson, A. J., Moseley, I. F., Macmanus, D. G., McDonald, W. I. & Miller, D. H. 1998 Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J. Neurol. Neurosurg. Psychiatr. 64, 353-357.
168. Osterman, P. O. 1976 Paroxysmal itching in multiple sclerosis. Br. J. Dermatol. 95, 555-558.
169. Osterman, P. O. & Westerberg, C. E. 1975 Paroxysmal attacks in multiple sclerosis. Brain 98, 189-202.
170. Paintal, A. S. 1966 The influence of diameter of medullated nerve fibres of cats on the rising and falling phases of the spike and its recovery. J. Physiol. (Lond.} 184, 791-811.
171. Park, H. J., Won, C. K., Pyun, K. H. & Shin, H. C. 1995 Interleukin 2 suppresses afferent sensory transmission in the primary somatosensory cortex. NeuroReport 6, 1018-1020.
172. Pencek, T. L., Schauf, C. L., Low, P. A., Eisenberg, B. R. & Davis, F. A. 1980 Disruption of the perineurium in amphibian peripheral nerve: morphology and physiology. Neurology 30, 593-599.
173. Pender, M. P. 1988a The pathophysiology of acute experimental allergic encephalomyelitis induced by whole spinal cord in the Lewis rat. J. Neurol. Sci. 84, 209-222.
174. Pender, M. P. 1988b The pathophysiology of myelin basic protein-induced acute experimental allergic encephalomyelitis in the Lewis rat. J. Neurol. Sci. 86, 277-289.
175. Pender, M. P. 1989 Recovery from acute experimental allergic encephalomyelitis in the Lewis rat. Early restoration of nerve conduction and repair by Schwann cells and oligodendrocytes. Brain 112, 393-416.
176. Pender, M. P. & Sears, T. A. 1981 The pathophysiology of acute experimental allergic encephalomyelitis in the rabbit. Brain 107, 699-726.
177. Petersen, P., Kastrup, J., Zeeberg, I. & Boysen, G. 1986 Chronic pain treatment with intravenous lidocaine. Neurol. Res. 8, 189-190.
178. Phadke, J. G. & Best, P. V. 1983 Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J. Neurol. Neurosurg. Psychiatr. 46, 414-420.
179. Prineas, J. W. & Connell, F. 1979 Remyelination in multiple sclerosis. Ann. Neurol. 5, 22-31.
180. Prineas, J. W., Kwon, E. E., Sharer, L. R. & Cho, E.-S. 1987 Massive early remyelination in acute multiple sclerosis. Neurology 37 (Suppl. 1), 109.
181. Princas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R. & Cho, E. S. 1993 Multiple sclerosis: remyelination of nascent lesions. Ann. Neurol. 33, 137-151.
182. Rasminsky, M. 1973 The effects of temperature on conduction in demyelinated single nerve fibers. Arch. Neurol. 28, 287-292.
183. Rasminsky, M. 1978 Ectopic generation of impulses and cross-talk in spinal nerve roots of 'dystrophic' mice. Ann. Neurol. 3, 351-357.
184. Rasminsky, M. 1980 Ephaptic transmission between single nerve fibres in the spinal nerve roots of dystrophic mice. J. Physiol. (Lond) 305, 151-169.
185. Rasminsky, M. 1981 Hyperexcitability of pathologically myelimated axons
186. Rasminsky, M. 1987 Spontaneous activity and cross-talk in pathological nerve fibers. Res. Publ. Assoc. Res. Nerv. Meat. Dis. 65, 39-49.
187. Rasminsky, M. & Sears, T. A. 1972 Internodal conduction in undissected demyelinated nerve fibres. J. Physiol. (Lond.} 227, 323-350.
188. Redford, E. J., Kapoor, R. & Smith, K. J. 1997 Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 120, 2149-2157.
189. Revesz, T., Kidd, D., Thompson, A. J., Barnard, R. O. & McDonald, W. I. 1994 A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117, 759-765.
190. Ridet, J. L., Malhotra, S. K., Privat, A. & Gage, E. H. 1997 Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
191. Rivera-Quinones, C., McGavern, D., Schmelzer, J. D., Hunter, S. F., Low, P. A. & Rodriguez, M. 1998 Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4, 187-193.
192. + channel heterogeneity. Eur. Neurol. 36, 3-12.
193. Robinson, K. & Rudge, P. 1977 Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. Brain 100, 19-40.
194. Rosenbluth, J. & Blakcmore, W. F. 1984 Structural specializations in cat of chronically demyelinated spinal cord axons as seen in freeze-fracture replicas. Neurosci. Lett. 48, 171-177.
195. Rosenbluth, J., Tao-Cheng, J.-H. & Blakemore, W. F. 1985 Dependence of axolemmal differentiation on contact with glial cells in chronically demyelinated lesions of cat spinal cord. Brain Res. 358, 287-302.
196. Rushton, W. A. H. 1937 Initiation of the propagated disturbance. Proc. R. Soc. Lond. B124, 210-243.
197. Schauf, C. L. & Davis, F. A. 1974 Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents. J. Neurol. Neurosurg. Psychiatr. 37, 152-161.
198. Schauf, C. L. & Davis, F. A. 1978 The occurrence, specificity, and role of neuroelectric blocking factors in multiple sclerosis. Neurology 28, 34-39.
199. Schauf, C. L. & Davis, F. A. 1981 Circulating toxic factors in multiple sclerosis: a perspective. Adv. Neurol. 31, 267-280.
200. Schauf, C. L., Davis, F. A., Sack, D. A., Reed, B. J. & Kesler, R. L. 1976 Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord. J. Neurol. Neurosurg. Psychiatr. 39, 680-685.
201. Schauf, C. L., Schauf, V., Davis, F. A. & Mizen, M. R. 1978 Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis. Neurology 28, 426-430.
202. Schoepfle, G. M. & Erlanger, J. 1941 The action of temperature on the excitability, spike height and configuration and the absolute refractory period observed in the responses of single medullated nerve fibers. Am. J. Physiol. 134, 694-704.
203. Schwarz, J. R. & Grigat, G. 1989 Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibres. Epilepsia 30, 286-294.
204. Schwid, S. R., Petrie, M. D. McDermott, M. P., Tierney, D. S., Mason, D. H. & Goodman, A. D. 1997 Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis. Neurology 48, 817-821.
205. Sclabassi, R. J., Namerow, N. S. & Enns, N. F. 1974 Somatosensory response to stimulus trains in patients with multiple sclerosis. Electroenceph. Clin. Neurophysiol. 37, 23-33.
206. Sears, T. A. & Bostock, H. 1981 Conduction failure in demyelination: is it inevitable? Adv. Neurol. 31, 357-375.
207. Sears,T. A., Bostock, H. & Sheratt, M. 1978 The pathophysiology of demyelination and its implications for the symptomatic treatment of multiple sclerosis. Neurology 28, 21-26.
208. Seil, F. J., Smith, M. E., Leiman, A. L. & Kelly, J. M. 1975 Myelination inhibiting and neuroelectric blocking factors in experimental allergic encephalomyelitis. Science 187, 951-953.
209. Seil, F. J., Leiman, A. L. & Kelly, J. M. 1976 Neuroelectric blocking factors in multiple sclerosis and normal human sera. Arch. Neurol. 33, 418-422.
210. Selhorst, J. B. & Saul, R. F. 1995 Uhthoff and his symptom. J. Neuro-Ophthalmol. 15, 63-69.
211. Sherratt, R. M., Bustock, H. & Sears, T. A. 1980 Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres. Nature 283, 570-572.
212. Shibasaki, H., McDonald, W. I. & Koroiwa, Y. 1981 Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J. Neurol. Sci. 49, 253-271.
213. Shrager, P. 1993 Axonal coding of action potentials in demyelinated nerve fibers. Brain Res. 619, 278-290.
214. Shrager, P. & Rubinstein, C. T. 1990 Optical measurement of conduction in single demyelinated axons. J. Gen. Physiol. 95, 867-890.
215. Shrager, P., Ouster, A. W., Kazarinova, K., Rasband, M. N. & Mattson, D. 1998 Nerve conduction block by nitric oxide that is mediated by the axonal environment. J. Neurophysiol. 79, 529-536.
216. Silver, N. C., Good, C. D., Barker, G. J., MacManus, D. J., Thompson, A. J., Moseley, I. F., McDonald, W. I. & Miller, D. H. 1997 Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 120, 1149-1461.
217. Sims, T. J., Gilmore, S. A. & Waxman, S. G. 1991 Radial glia give rise to perinodal processes. Brain Res. 549, 25-35.
218. Small, D. G., Matthews, W. B. & Small, M. 1978 The cervical somatosensory evoked potential (SEP) in the diagnosis of multiple sclerosis. J. Neurol. Sci 35, 211-224.
219. Smith, K. J. 1994 Conduction properties of central demyelinated and remyelinated axons, and their relation to symptom production in demyelinating disorders. Eye 8, 224-237.
220. Smith, K. J. & McDonald, W. I. 1980 Spontaneous and mechanically evoked activity due to central demyelinating lesion. Nature 286, 154-155.
221. Smith, K. J. & McDonald,W. I. 1982 Spontaneous and evoked electrical discharges from a central demyelinating lesion. J. Neurol. Sci. 55, 39-47.
222. Smith, K. J., Blakemore, W. F. & McDonald, W I. 1979 Central remyelination restores secure conduction. Nature 280, 395-396.
223. Smith, K. J., Blakemore, W. F. & McDonald, W. I. 1981 The restoration of conduction by central remyelination. Brain 104, 383-404.
224. Smith, K. J., Bostock, H. & Hall, S. M. 1982 Saltatory conduction precedes remyelination in axons demyelinated with lysophosphatidyl choline. J. Neurol. Sci. 54, 13-31.
225. Smith, K. J., Felts, P. A. & Kapoor, R. 1997 Axonal hyperexcitability: mechanisms and role in symptom production in demyelinating diseases. Neuroscientist 3, 237-246.
226. Smith, K. J., Felts, P. A. & John, G. R. 2000 Effects of 4-aminopyridine on demyelinated axons, synapses and muscle tension. Brain. (In the press.)
227. Sorkin, L. S., Xiao, W. H., Wagner, R. & Myers, R. R. 1997 Tumour necrosis factor-alpha induces cetopic activity in nociceptive primary afferent fibres. Neuroscience 81, 255-262.
228. Stefoski, D., Schauf, C. L., McLeod, B. C., Haywood, C. P. & Davis, F. A. 1982 Plasmapheresis decreases neuroelectric blocking activity in multiple sclerosis. Neurology 32, 904-907.
229. Stephanova, D. I. & Chobanova, M. 1097 Action potentials and ionic currents through paranodally demyelinated human motor nerve fibres: computer simulations. Biol. Cybernet. 76, 311-314.
230. Stewart, V. G., Giovannoni, G., Land, J. M., McDonald, W. I., Clark, J. B. & Heales, S. J. 1997 Pretreatment of astrocytes with interferon-alpha/beta impairs interferon-gamma induction of nitric oxide synthase. J. Neurochem. 68, 2547-2551.
231. Stewart, W. A., Hall, L. D., Beary, K. & Paty, D. W. 1984 Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 324, 412.
232. + conductance in rat optic nerve axons. Proc. Natl Acad. Sci. USA 90, 6976-6980.
233. Tancredi V., D'Arcangelo, G., Grassi, F., Tarroni, P., Palmieri, G., Santoni, A. & Eusebi, F. 1992 Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neurosci, Lett. 146, 176-178.
234. Targ, E. F. & Kocsis, J. D. 1985 4-Aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve. Brain Res. 328, 358-361.
235. Tasaki, I. 1953 Nervous transmission. Springfield, IL: Charles C. Thomas.
236. Thompson, A. J., Kermode, A. G., Wicks, D., Macmanus, D. G., Kendall, B. E., Kingsley, D. P. & McDonald, W. I. 1991 Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann. Neurol. 29, 53-62.
237. Titcombe, A. F. & Willison, R. G. 1961 Flicker fusion in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 24, 260-265.
238. Truyen, L., Van Waesberghe, J. H. T. M., Van Walderveen, M. A. A., Van Oosten, B. W., Polman, C. H., Hommes, O. R., Ader, H. J. A. & Barkhof, F. 1996 Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47, 1469-1476.
239. Uhthoff, W. 1890 Untersuchungen über die bei der multiplen Herdskletose vorkommenden Augenstörungen. Arch. Psychiatr. Nervenkrank. 21, 55-116.
240. Ulrich, J. & Grocbke-Lorenz, W. 1983 The optic nerve in multiple sclerosis: a morphological study with retrospective clinicopathological correlations. Neuro-ophthalmology 3, 149-159.
241. Utzschneider, D. A., Thio, C., Sontheimer, H., Ritchie, J. M. Waxman, S. G. & Koesis, J. D. 1993 Action potential conduction and sodium channel content in the optic nerve of the myelin-deficient rat. Proc. R. Soc. Lond. B254, 2-50.
242. Utzchneider, D. A., Archer, D. R., Koesis, J. D., Waxman, S. C. & Duncan, I. D. 1994 Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc. Natl Acad. Sci. USA 91, 53-57.
243. Van Walderveen, M. A. A., Kamphorst, W., Scheltern, P., Van Waesberghe, J. H. T. M., Ravid, R.,Valk, J., Polman, C. H. & Barkhof, F. 1998 Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 50, 1282-1288.
244. + channels in rat microglia. In First European Meeting on Glial Cell Function in Health and Disease. Heidelberg, Germany.
245. Waxman, S. G. 1981 Clinicopathological correlations in multiple sclerosis and related diseases. Adv. Neurol. 31, 169-182.
246. Waxman, S. G. 1989 Demyelination in spinal cord injury. J. Neurol. Sci. 91, 1-14.
247. Waxman, S. G. 1995 Sodium channel blockade by antibodies: a new mechanism of neurological disease? Ann. Neurol. 37, 421-423.
248. Waxman, S. G. & Brill, M. H. 1978 Conduction through demyelinated plaques in multiple sclerosis: computer simulations of facilitation by short internodes. J. Neurol. Neurosurg. Psychiatr. 41, 408-416.
249. Waxman, S. G. & Foster, R. E. 1980 Ionic channel distribution and heterogencity of the axon membrane in myelinated fibers. Brain res. 203, 205-234.
250. Waxman, S. G. & Geschwind, N. 1983 Major morbidity related to hyperthermia in multiple sclerosis. Ann. Neurol. 13, 348.
251. Waxman, S. G. & Ritchic, J. M. 1993 Molecular dissection of the myelinated axon. Ann. Neurol, 33, 121-136.
252. Waxman, S. G., Utzschneider, D. A. & Kocsis, J. D. 1994 Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury. Prog. Brain Res. 100, 233-243.
253. Weiller, C., Ramsay, S. G., Wise, R. J. S., Friston, K. J. & Frackowiak, R. S. J. 1993 Individual patterns of functional reorganization in the human cerebral cortex after capsular infarction. Ann. Neurol. 33, 181-189.
254. Werring, D. J., Miller, D. H., Bullmore, E. T., Barker, G. J., MacManus, D. G., Brammer, M. J., McDonald, W. I. & Thompson, A. J. 1999 Extensive brain activation following recovery from optic neuritis: a pilot study using functional magnetic resonance imaging (fMRI). Proc. Int. Soc. Magnet. Res. Med, 2, 942.
255. Willoughby, E. W., Grochowski, E., Li, D. K. B., Oger, J., Kastrukoff, L. F. & Paty D. W. 1989 Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann. Neurol. 25, 43-49.
256. Wisniewski, H. M., Oppenheimer, D. & McDonald, W. I. 1976 Relation between myelination and function in multiple sclerosis and EAE. J. Neuropathol. Exp. Neurol. 35, 327.
257. Woolf, G. J., Allchorne, A., Safich-Garabedian, B. & Poole., S. 1997 Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 121, 117-124.
258. Wu, J. V. & Shrager, P. 1994 Resolving three types of chloride channels in demyelinated Xenopus axons. J. Neurosci. Res. 38, 613-620.
259. Wu, J. V., Rubinstein, C. T. & Shrager, P. 1993 Single channel characterization of multiple types of potassium channels in demyelinated Xenopus axons. J. Neurosci. 13, 5153-5163.
260. 3-) levels in cerebrospinal fluid of patients with multiple sclerosis. J. Neurol. Sci. 153, 32-34.
261. Youl, B. D. (and H others) 1991 The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 114, 2437-2450.
262. Young, W., Rosenbluth, J., Wojak, J. C., Sakatani, K. & Kim, H. 1989 Extracellular potassium activity and axonal conduction in spinal cord of the myelin-deficient mutant rat. Exp. Neurol. 106, 41-51.
263. Yu, B. & Shinnick-Gallagher, P. 1994 Interleukin-1 beta inhibits synaptic transmission and induces membrane hyperpolarization in amygdala neurons. J. Pharmacol. Exp. Ther. 271, 590-600.